Insulin Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Pages: 143 Published: September 19, 2022 Report Code: GDME1435EPD

  • Overview
  • Key Players
  • Contents
  • Tables
  • Figures
  • FAQ
  • Listen
    iSpeech

An insulin pump administers programmed doses of insulin for diabetes management. The Insulin Pumps pipeline market research report provides comprehensive information about the Insulin Pumps pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Insulin Pumps Pipeline Products Market Territory Outlook

Some of the key territories with products in the pipeline are the US, Europe, China, Bahrain, Canada, India, Israel, Kuwait, Oman, and Qatar. As of September 2022, the US has the highest number of products in the pipeline out of them all.

Insulin Pumps Pipeline Products Market Analysis, by Territories

Insulin Pumps Pipeline Products Market Analysis, by Territories

For more territory insights into the insulin pumps pipeline market, download a free report sample

Insulin Pumps Pipeline Products Market by Key Segments

The key segments in the Insulin pumps pipeline products market are Patch Pumps, Programmable Insulin Patch Pumps – Pods, and Disposable Insulin Pumps. Patch Pumps have the highest number of products in the pipeline.

Insulin Pumps Pipeline Products Market Analysis, by Segments

Insulin Pumps Pipeline Products Market Analysis, by Segments

For more insulin pumps pipeline market segment insights, download a free report sample

Insulin Pumps Pipeline Products Market Segmentation by Key Regulatory Paths

The key regulatory paths followed by the Insulin pumps pipeline products market are 510(k), CE, NMPA, PMA, ICAC, MDITAC, and MDL. Most of the products follow the 510(k) pathway to enter the market.

Insulin Pumps Pipeline Products Market Analysis, by Regulatory Paths

Insulin Pumps Pipeline Products Market Analysis, by Regulatory Paths

For more insulin pumps pipeline market regulatory path insights, download a free report sample

Competitive Landscape

Some of the key companies in the Insulin pumps pipeline products market are AMF Medical SA, Amrita Vishwa Vidyapeetham, Andain, Inc, Becton Dickinson and Co, Cellnovo Ltd (Inactive), Debiotech SA, EOFlow Co Ltd, Hospira Inc, Insulet Corp, and Kailian Medical Technology Co Ltd.

AMF Medical SA: They develop novel technology to address the unmet needs of people on insulin therapy. AMF Medical is headquartered in Ecublens, Switzerland.

Amrita Vishwa Vidyapeetham: They offer degree courses in the discipline of engineering, communication, social work and many more. It is headquartered in Coimbatore, Tamil Nadu, India. 

Becton Dickinson and Co: It is a medical technology company which manufactures and sells medical devices, reagents, and instruments. BD offers its products for life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry, and the general public. The company sells its products in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. BD is headquartered in New Jersey, the US.

Insulin Pumps Pipeline Products Market Report Overview

Key Territories The US, Europe, China, Bahrain, Canada, India, Israel, Kuwait, Oman, and Qatar
Key Segments Patch Pumps, Programmable Insulin Patch Pumps – Pods, and Disposable Insulin Pumps
Key Regulatory Paths 510(k), CE, NMPA, PMA, ICAC, MDITAC, and MDL
Key Companies AMF Medical SA, Amrita Vishwa Vidyapeetham, Andain, Inc, Becton Dickinson and Co, Cellnovo Ltd (Inactive), Debiotech SA, EOFlow Co Ltd, Hospira Inc, Insulet Corp, and Kailian Medical Technology Co Ltd

Scope

This report provides:

  • Extensive coverage of the Insulin Pumps under development.
  • Details of major pipeline products which include product description, licensing, collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of Insulin Pumps and lists all their pipeline projects.
  • The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Insulin Pumps under development.
  • Develop market-entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Key Players

AMF Medical SA

Amrita Vishwa Vidyapeetham

Andain, Inc

Becton Dickinson and Co

Cellnovo Ltd (Inactive)

Debiotech SA

EOFlow Co Ltd

Hospira Inc

Insulet Corp

Kailian Medical Technology Co Ltd

LifeScan Inc

MedSolve Technologies, Inc.

Medtronic MiniMed Inc

Medtronic Plc

MicroPort Scientific Corp

MicroTech Medical Co Ltd

Modular Medical Inc

Pennsylvania State University

Phluid Corporation

PhysioLogic Devices Inc

Qlibrium Inc

SFC Fluidics LLC

Sooil Development Co., Ltd.

Spring Health Solutions Ltd.

Tandem Diabetes Care Inc

Thermalin Inc

Triple Jump Israel Ltd

University of Limerick

Univlabs Technologies Pvt Ltd

ViCentra BV

Ypsomed Holding AG

Table of Contents

1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 11

2 Introduction 12

2.1 Insulin Pumps Overview 12

3 Products under Development 13

3.1 Insulin Pumps – Pipeline Products by Stage of Development 13

3.2 Insulin Pumps – Pipeline Products by Segment 14

3.3 Insulin Pumps – Pipeline Products by Territory 15

3.4 Insulin Pumps – Pipeline Products by Regulatory Path 16

3.5 Insulin Pumps – Pipeline Products by Estimated Approval Date 17

3.6 Insulin Pumps – Ongoing Clinical Trials 18

4 Insulin Pumps – Pipeline Products under Development by Companies 19

4.1 Insulin Pumps Companies – Pipeline Products by Stage of Development 19

4.2 Insulin Pumps – Pipeline Products by Stage of Development 21

5 Insulin Pumps Companies and Product Overview 23

5.1 AMF Medical SA Company Overview 23

5.1.1 AMF Medical SA Pipeline Products & Ongoing Clinical Trials Overview 23

5.2 Amrita Vishwa Vidyapeetham Company Overview 24

5.2.1 Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 24

5.3 Andain, Inc Company Overview 25

5.3.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.4 Becton Dickinson and Co Company Overview 27

5.4.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 27

5.5 Cellnovo Ltd (Inactive) Company Overview 28

5.5.1 Cellnovo Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 28

5.6 Debiotech SA Company Overview 29

5.6.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 29

5.7 EOFlow Co Ltd Company Overview 31

5.7.1 EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

5.8 Hospira Inc Company Overview 32

5.8.1 Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.9 Insulet Corp Company Overview 33

5.9.1 Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview 33

5.10 Kailian Medical Technology Co Ltd Company Overview 39

5.10.1 Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

5.11 LifeScan Inc Company Overview 41

5.11.1 LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview 41

5.12 MedSolve Technologies, Inc. Company Overview 42

5.12.1 MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42

5.13 Medtronic MiniMed Inc Company Overview 43

5.13.1 Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.14 Medtronic Plc Company Overview 54

5.14.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 54

5.15 MicroPort Scientific Corp Company Overview 55

5.15.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 55

5.16 MicroTech Medical Co Ltd Company Overview 57

5.16.1 MicroTech Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

5.17 Modular Medical Inc Company Overview 59

5.17.1 Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.18 Pennsylvania State University Company Overview 61

5.18.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 61

5.19 Phluid Corporation Company Overview 62

5.19.1 Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview 62

5.20 PhysioLogic Devices Inc Company Overview 63

5.20.1 PhysioLogic Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.21 Qlibrium Inc Company Overview 64

5.21.1 Qlibrium Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.22 SFC Fluidics LLC Company Overview 65

5.22.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 65

5.23 Sooil Development Co., Ltd. Company Overview 68

5.23.1 Sooil Development Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 68

5.24 Spring Health Solutions Ltd. Company Overview 69

5.24.1 Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 69

5.25 Tandem Diabetes Care Inc Company Overview 70

5.25.1 Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.26 Thermalin Inc Company Overview 76

5.26.1 Thermalin Inc Pipeline Products & Ongoing Clinical Trials Overview 76

5.27 Triple Jump Israel Ltd Company Overview 79

5.27.1 Triple Jump Israel Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

5.28 University of Limerick Company Overview 80

5.28.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 80

5.29 Univlabs Technologies Pvt Ltd Company Overview 81

5.29.1 Univlabs Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 81

5.30 ViCentra BV Company Overview 82

5.30.1 ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview 82

5.31 Ypsomed Holding AG Company Overview 84

5.31.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 84

6 Insulin Pumps- Recent Developments 89

6.1 Sep 07, 2022: Medtronic to appear at September investor conferences 89

6.2 Sep 06, 2022: LifeScan Names Rekha Ramesh Chief Digital and Information Officer 89

6.3 Aug 31, 2022: Lilly to Participate in Morgan Stanley 20th Annual Global Healthcare Conference 89

6.4 Aug 25, 2022: Lilly to Participate in Citi’s 17th Annual BioPharma Conference 89

6.5 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 90

6.6 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 92

6.7 Aug 22, 2022: Tandem Diabetes Care Announces Upcoming Conference Presentations 95

6.8 Jul 28, 2022: Integer Holdings Reports Second Quarter 2022 Results 95

6.9 Jul 21, 2022: Roche: Appointed Thomas Schinecker as New CEO Effective March 15, 2023 96

6.10 Jul 21, 2022: Lilly Confirms Date and Conference Call for Second-Quarter 2022 Financial Results Announcement 96

6.11 Jul 20, 2022: Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance 97

6.12 Jul 12, 2022: Tandem Diabetes Care to Announce Second Quarter 2022 Financial Results on August 3 2022 97

6.13 Jul 09, 2022: Modular Medical Announces Participation at Upcoming Investor Conferences 98

6.14 Jun 30, 2022: Annual General Meeting of Ypsomed elects new Chairman 98

6.15 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 98

6.16 Jun 27, 2022: Ist Kalbe Farma (KLBF) Subsidiary IPO Plan Delayed 99

6.17 Jun 03, 2022: Lilly to Participate in Goldman Sachs Global Healthcare Conference 99

6.18 Jun 03, 2022: Eli Lilly announces its new president and general manager for Latam 99

6.19 Jun 02, 2022: Insulet to Present at the William Blair & Company 42nd Annual Growth Stock Conference 100

6.20 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 100

6.21 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 100

6.22 May 16, 2022: EOFlow Announces Record Revenue for First Quarter 2022; Revenue of 949 Million KRW which is 137% of Last Year’s Annual Revenue 100

6.23 May 06, 2022: Mary Lynne Hedley Elected to Lilly Board of Directors 101

6.24 May 05, 2022: Insulet Announces CEO Transition 101

6.25 May 05, 2022: Insulet Reports First Quarter 2022 Revenue Increase of 17% Year-Over-Year 103

6.26 May 04, 2022: Tandem Diabetes Care Announces First Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance 104

6.27 May 03, 2022: Lilly to Participate in Bank of America Securities 2022 Healthcare Conference 106

6.28 Apr 28, 2022: Integer Holdings Corporation Reports First Quarter 2022 Results 106

6.29 Apr 07, 2022: Insulet to Announce First Quarter 2022 Financial Results on May 5, 2022 108

6.30 Mar 30, 2022: ConvaTec Group announces Annual Report and Accounts 2021 and Notice of AGM 108

6.31 Mar 24, 2022: Integer Schedules First Quarter 2022 Earnings Release and Conference Call for April 28, 2022 109

6.32 Mar 17, 2022: Integer Announces Board Leadership Transition 109

6.33 Mar 17, 2022: Integer to Take Part in a Virtual Fireside Chat at the KeyBanc Life Sciences & MedTech Investor Forum 109

6.34 Mar 17, 2022: ConvaTec Group Announces Board Change 110

6.35 Mar 15, 2022: Opentrons Labworks Appoints Chief Financial Officer, and Chief Legal and Compliance Officer 110

6.36 Mar 10, 2022: EOFlow Announces Board Member Change to Sharpen its Focus on the US Market 110

6.37 Mar 08, 2022: ConvaTec Group Annual Results for the twelve months ended 31 December 2021 111

6.38 Mar 08, 2022: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2021 112

6.39 Feb 23, 2022: Ypsomed focuses on growth and strengthens its business units 116

6.40 Feb 18, 2022: Shanghai MicroPort Medical Group announces Chairman of the Board of Directors, Chairman of the Supervisory Committee, and Senior Management Announcement 117

6.41 Feb 16, 2022: Insulet to Present at Upcoming Investor Conferences 117

6.42 Feb 07, 2022: Insulet Announces Board Appointment of Elizabeth Weatherman and Retirement of David Lemoine 117

6.43 Feb 03, 2022: Roche reports good results in 2021 118

6.44 Feb 03, 2022: F. Hoffmann-La Roche Announces Financial Results for fiscal 2021 122

6.45 Jan 27, 2022: ConvaTec Group Announce Board Committee Changes 122

6.46 Jan 22, 2022: Eoflow participates in JP Morgan Healthcare Conference 122

6.47 Jan 18, 2022: Eoflow, ESG/Ethical Management Proclamation Ceremony held 123

6.48 Jan 12, 2022: Insulet to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2021 123

6.49 Jan 11, 2022: EOFlow to participate in the JP Morgan Healthcare Conference 124

6.50 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference 124

6.51 Dec 22, 2021: Eoflow, selected as one of the ‘National Innovative Companies 1000’ in the field of health and diagnosis 124

6.52 Dec 09, 2021: Convatec Announces Chief Financial Officer succession 125

6.53 Dec 03, 2021: Roche Announces Changes in the Board of Directors 126

6.54 Dec 02, 2021: Tandem Diabetes Care Announces Expansion of Senior Leadership Team 126

6.55 Nov 27, 2021: Supporting the national healthcare industry’s security, Kalbe open opportunities for domestic production cooperation 127

6.56 Nov 26, 2021: Roche Notice Extraordinary General Meeting 2021 127

6.57 Nov 18, 2021: Tandem Diabetes Care to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference 128

6.58 Nov 18, 2021: MicroPort RehabTech TherMotion Cryo-Thermo compression device approved for marketing in China 128

6.59 Nov 11, 2021: Targeting patients of cancer, thallasemia, HIV/AIDS and other autoimmune diseases Kalbe and Hermina Hospital held a Covid-19 vaccination center in Bandung 128

6.60 Nov 10, 2021: Kalbe develops surgical suture product domestically produced 129

6.61 Nov 04, 2021: Tandem Diabetes Care Announces Third Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance 130

6.62 Nov 04, 2021: Insulet Reports Third Quarter 2021 Revenue Increase of 18% Year-Over-Year 131

6.63 Nov 04, 2021: Ypsomed is growing and expects a further increase 132

6.64 Oct 28, 2021: Integer Holdings Reports Third Quarter 2021 Results 134

6.65 Oct 20, 2021: F. Hoffmann-La Roche Announces Third Quarter Sales 2021 135

6.66 Oct 18, 2021: Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford 135

6.67 Oct 15, 2021: Kalbe holds Covid-19 vaccination center for patients of cancer, thallasemia, HIV/AIDS and other autoimmune diseases 136

6.68 Oct 15, 2021: Kalbe optimistic to achieve double-digit growth 136

6.69 Oct 07, 2021: Tandem Diabetes Care to Announce Third Quarter 2021 Financial Results on November 3, 2021 137

6.70 Oct 07, 2021: Construction begins on 280,000-square-meter MicroPort MegaFactory and global medical experience center 137

6.71 Oct 05, 2021: Kalbe and Kompas Gramedia held the second-dose vaccination center for the people of Pekanbaru 138

6.72 Sep 29, 2021: Insulet to Announce Third Quarter 2021 Financial Results on November 4, 2021 139

6.73 Sep 28, 2021: Integer Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021 139

7 Appendix 140

7.1 Methodology 140

7.2 About GlobalData 143

7.3 Contact Us 143

7.4 Disclaimer 143

List of Tables

Insulin Pumps – Pipeline Products by Stage of Development 13

Insulin Pumps – Pipeline Products by Segment 14

Insulin Pumps – Pipeline Products by Territory 15

Insulin Pumps – Pipeline Products by Regulatory Path 16

Insulin Pumps – Pipeline Products by Estimated Approval Date 17

Insulin Pumps – Ongoing Clinical Trials 18

Insulin Pumps Companies – Pipeline Products by Stage of Development 19

Insulin Pumps – Pipeline Products by Stage of Development 21

AMF Medical SA Pipeline Products & Ongoing Clinical Trials Overview 23

Sigi Insulin Management System – Product Status 23

Sigi Insulin Management System – Product Description 23

Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 24

Amrita Insulin Pump – Product Status 24

Amrita Insulin Pump – Product Description 24

Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Gaia Med Diamond Semi-Disposable Pump – Product Status 25

Gaia Med Diamond Semi-Disposable Pump – Product Description 25

Gemini Pump – Product Status 26

Gemini Pump – Product Description 26

Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 27

Type 2 Patch Pump – Product Status 27

Type 2 Patch Pump – Product Description 27

Cellnovo Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 28

Wireless Insulin Pump System Integrated With inControl AP – Product Status 28

Wireless Insulin Pump System Integrated With inControl AP – Product Description 28

Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 29

JewelPump – Product Status 29

JewelPump – Product Description 29

JewelPUMP2 – Product Status 30

JewelPUMP2 – Product Description 30

EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

EOPatch Wearable Insulin Pump System – Product Status 31

EOPatch Wearable Insulin Pump System – Product Description 31

Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Integrated Symbiq/EndoTool System – Product Status 32

Integrated Symbiq/EndoTool System – Product Description 32

Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview 33

Omnipod 5 – Product Status 33

Omnipod 5 – Product Description 34

Omnipod U-200 Insulin Management System – Product Status 34

Omnipod U-200 Insulin Management System – Product Description 34

Omnipod U-500 Insulin Management System – Product Status 35

Omnipod U-500 Insulin Management System – Product Description 35

Insulet Corp – Ongoing Clinical Trials Overview 36

Omnipod 5 – Automated Insulin Delivery for Inpatients with DysGlycemia (AIDING) Feasibility Study 37

Omnipod 5 – Efficacy and Safety of the Omnipod 5 System Compared to Pump Therapy in the Treatment of Type 1 Diabetes: A Randomized, Parallel-Group Clinical Trial 37

Omnipod 5 – Evaluating the Safety and Effectiveness of the Omnipod 5 Automated Insulin Delivery System in Patients with Type 2 Diabetes 37

Omnipod 5 – Evaluating the Safety and Effectiveness of the Omnipod Horizon Automated Glucose Control System in Patients with Type 1 Diabetes 38

Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

InnoTouch Insulin Application Pump – Product Status 39

InnoTouch Insulin Application Pump – Product Description 39

Le Pump Insulin Pump II – Product Status 40

Le Pump Insulin Pump II – Product Description 40

Lenomed ATA-I-1-0 Insulin Pump – Product Status 40

Lenomed ATA-I-1-0 Insulin Pump – Product Description 40

LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview 41

ONETOUCH Ping Verio Insulin Pump With Meter Remote – Product Status 41

ONETOUCH Ping Verio Insulin Pump With Meter Remote – Product Description 41

MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42

Freehand Patch Pump – Product Status 42

Freehand Patch Pump – Product Description 42

Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Minimed 780G – Adults – Product Status 43

Minimed 780G – Adults – Product Description 43

Minimed 780G – Pediatric – Product Status 44

Minimed 780G – Pediatric – Product Description 44

Medtronic MiniMed Inc – Ongoing Clinical Trials Overview 45

Minimed 780G – Adults – Advanced Hybrid Closed Loop Study in Adult Population with Type 1 Diabetes 47

Minimed 780G – Adults – Advanced Hybrid Closed-Loop Treatment in Adults with Type 1 Diabetes Not Meeting Glycaemic Targets: A Randomized Controlled Trial – The Steno 780G Study 47

Minimed 780G – Adults – Closed-loop Insulin Delivery in Pregnant Women with Type 1 Diabetes: A Randomized Controlled Trial: The CRISTAL Study 47

Minimed 780G – Adults – Effect of Automated Insulin Delivery with Advanced Closed-loop on Glucose Outcomes and Early-stage Diabetic Complications 48

Minimed 780G – Adults – Evaluation of the MiniMed 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp (Insulin Aspart Injection) 48

Minimed 780G – Adults – Evaluation of Two Levels of Health Care Interactions in Adolescents with Type 1 Diabetes on Advanced Hybrid Closed Loop System MiniMed 780G/ Zeus Sensor 48

Minimed 780G – Adults – Feasibility Study for a Medtronic next Generation Hybrid Closed Loop System in Adults with Type 1 Diabetes 49

Minimed 780G – Adults – In-Home Study With MiniMed 780G Pump Automated Control in Type 2 – Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes 49

Minimed 780G – Adults – Optimising Glycaemia Around Dynamic Physical Exercise with Advanced Hybrid-closed-loop Therapy Use in Type 1 Diabetes: ‘The SMART Study’ 49

Minimed 780G – Adults – Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects 50

Minimed 780G – Adults – Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev Insulin Lispro-aabc 50

Minimed 780G – Adults – The MiniMed 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects with Type 1 Diabetes in France: EQOL Study 50

Minimed 780G – Adults – Transition of Patients with T1D From Multiple Daily Injection (MDI) and Self-monitoring of Blood Glucose (SMBG) Directly to MiniMed 780G Advanced Hybrid Closed Loop (AHCL) System :Impact on Glucose Control and Quality of Life Measures 51

Minimed 780G – Pediatric – Assessment of the Efficacy of Closed Loop Technology for Glucose Control in Young Children with Type 1 Diabetes 52

Minimed 780G – Pediatric – Assessment of the Feasibility of Using Closed Loop Technology in Young Children with Type 1 Diabetes Aged 2-7 52

Minimed 780G – Pediatric – Evaluation of the MiniMed 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp (Insulin Aspart Injection) 52

Minimed 780G – Pediatric – Evaluation of Two Levels of Health Care Interactions in Adolescents with Type 1 Diabetes on Advanced Hybrid Closed Loop System MiniMed 780G/ Zeus Sensor 53

Minimed 780G – Pediatric – Glycemic Outcomes and Safety with Minimed 780G System in Children with Type 1 Diabetes Aged 2-6 Years 53

Minimed 780G – Pediatric – Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev Insulin Lispro-aabc 53

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 54

Implantable Insulin Pump – Product Status 54

Implantable Insulin Pump – Product Description 54

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 55

Angel Touch – Product Status 55

Angel Touch – Product Description 55

La Fenice V – Product Status 56

La Fenice V – Product Description 56

MicroTech Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

Equil Insulin Pump – Child and Adolescent Use – Product Status 57

Equil Insulin Pump – Child and Adolescent Use – Product Description 57

Second-Generation Patch Insulin Pump System – Product Status 58

Second-Generation Patch Insulin Pump System – Product Description 58

Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 59

MODD1 (MODD Pivot) – Product Status 59

MODD1 (MODD Pivot) – Product Description 59

MODD1+ – Product Status 60

MODD1+ – Product Description 60

Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 61

Nanobot Based Insulin Pumping Device – Product Status 61

Nanobot Based Insulin Pumping Device – Product Description 61

Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview 62

Ambulatory Diabetes Pump – Product Status 62

Ambulatory Diabetes Pump – Product Description 62

PhysioLogic Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 63

ThinPump – Product Status 63

ThinPump – Product Description 63

Qlibrium Inc Pipeline Products & Ongoing Clinical Trials Overview 64

QForma – Product Status 64

QForma – Product Description 64

SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 65

Dual ePump – Product Status 65

Dual ePump – Product Description 65

Open-Protocol Patch Pump System – Product Status 66

Open-Protocol Patch Pump System – Product Description 66

PANDA – Product Status 66

PANDA – Product Description 67

Pod Automated Insulin Delivery Device – Product Status 67

Pod Automated Insulin Delivery Device – Product Description 67

Sooil Development Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 68

Dana-I Pump – Product Status 68

Dana-I Pump – Product Description 68

Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 69

Spring Zone Hybrid Patch Pump – Product Status 69

Spring Zone Hybrid Patch Pump – Product Description 69

Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 70

SteadiSet Infusion Set – Product Status 70

SteadiSet Infusion Set – Product Description 71

t:slim X3 Insulin Pump – Product Status 71

t:slim X3 Insulin Pump – Product Description 71

Tandem Mobi – Product Status 72

Tandem Mobi – Product Description 72

Tandem Mobi: Tubeless – Product Status 72

Tandem Mobi: Tubeless – Product Description 73

Tandem Diabetes Care Inc – Ongoing Clinical Trials Overview 74

SteadiSet Infusion Set – A Pivotal, Non-randomized, Prospective and Single Arm Study to Evaluate SteadiFlow Seven-day-wear Infusion Set Technology in Type I Diabetes Subjects 75

Thermalin Inc Pipeline Products & Ongoing Clinical Trials Overview 76

Stabilized and Ultra-Rapid Insulin Pump – Product Status 76

Stabilized and Ultra-Rapid Insulin Pump – Product Description 76

StampPump – Product Status 77

StampPump – Product Description 77

Ultra-Rapid Highly-Concentrated Insulin Pump – Product Status 77

Ultra-Rapid Highly-Concentrated Insulin Pump – Product Description 78

Triple Jump Israel Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

Insulin Patch Pump – Product Status 79

Insulin Patch Pump – Product Description 79

University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 80

Smart Gluco – Product Status 80

Smart Gluco – Product Description 80

Univlabs Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 81

Wearable Insulin Patch Pump – Product Status 81

Wearable Insulin Patch Pump – Product Description 81

ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview 82

Kaleido Insulin Pump – Product Status 82

Kaleido Insulin Pump – Product Description 82

Kaleido Insulin Pump – Children And Adolescent – Product Status 83

Kaleido Insulin Pump – Children And Adolescent – Product Description 83

Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 84

Lanzi – Product Status 84

Lanzi – Product Description 84

Mylife Dose – Product Status 85

Mylife Dose – Product Description 85

mylife YpsoPod Insulin Pump – Tubeless – Product Status 85

mylife YpsoPod Insulin Pump – Tubeless – Product Description 86

mylife YpsoPump – Product Status 86

mylife YpsoPump – Product Description 86

Ypsomed Holding AG – Ongoing Clinical Trials Overview 87

mylife YpsoPump – Feasibility of Automated Insulin Delivery with an Interoperable Algorithm Using an Alternative Insulin Pump 88

mylife YpsoPump – First in Human Feasibility Study; Automated Insulin Delivery Utilizing the Dexcom Next Generation Algorithm in Adults with Type 1 Diabetes 88

Glossary 142

List of Figures

Insulin Pumps – Pipeline Products by Stage of Development 13

Insulin Pumps – Pipeline Products by Segment 14

Insulin Pumps – Pipeline Products by Territory 15

Insulin Pumps – Pipeline Products by Regulatory Path 16

Insulin Pumps – Pipeline Products by Estimated Approval Date 17

Insulin Pumps – Ongoing Clinical Trials 18

Frequently Asked Questions

The US, Europe, China, Bahrain, Canada, India, Israel, Kuwait, Oman, and Qatar have products in the pipeline.

The key segments in the Insulin pumps pipeline products market are Patch Pumps, Programmable Insulin Patch Pumps – Pods, and Disposable Insulin Pumps.

The key regulatory paths followed by the Insulin pumps pipeline products market are 510(k), CE, NMPA, PMA, ICAC, MDITAC, and MDL.

The key companies in the Insulin pumps pipeline products market are AMF Medical SA, Amrita Vishwa Vidyapeetham, Andain, Inc, Becton Dickinson and Co, Cellnovo Ltd (Inactive), Debiotech SA, EOFlow Co Ltd, Hospira Inc, Insulet Corp, and Kailian Medical Technology Co Ltd.

$4000

Can be used by individual purchaser only

$12000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.